A

ANGO

ANGO

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
ANGO Live QuoteReal-time
$11.32
$0.49(-4.15%)1M
Day Range$11.19 – $11.61
Open$11.43
Previous Close$11.49
Volume323.0K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$476.06M
P/E Ratio (TTM)24.5
Forward P/E96.2
EPS (TTM)$-0.78
Price to Book3.0
Dividend Yield0.65%
Beta (Volatility)0.28
IndustryMEDICAL INSTRUMENTS & SUPPLIES
52-Week RangeCurrent: $11.32 (28%)
Low: $9.39High: $16.29
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$19.75-86.8% upside

Insider Buys

0

$0

Insider Sales

1

$311K

Total Volume

$311K

1 transactions

Net Activity

$311K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
T
1

Trowbridge Stephen A

EVP, CFO

0 buys1 sells

$311K total

Trading History
ANGO insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Oct 28, 2026

3 weeks ago

Trowbridge Stephen A

EVP, CFO

CFO
Sell25.3K$12.26$311K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
ANGO Buy Conviction0%
Industry Rank#419 of 563
Volume Contribution0.0%
Total Industry Activity$16.73B

ANGO has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%. ANGO ranks #419 in insider activity out of 563 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for ANGO

Over the last 90 days, corporate insiders at ANGO (ANGO) engaged in a total of 1 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 1 were sales. The total volume of insider trading reached $311K.

The net insider activity for ANGO shows a net selling bias of $311K. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Trowbridge Stephen A (EVP, CFO), who traded 25.3K shares valued at $311K on Oct 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for ANGO (ANGO)
6 updates

Anglo American plc (NGLOY) Stock Price, News, Quote & History

Yahoo! Finance CanadaYesterday

Angiodynamics Stock Price Forecast. Should You Buy ANGO?

StockInvest.us7d ago

AngioDynamics (ANGO) Reports Q1 Loss, Lags Revenue Estimates

Yahoo Finance42d ago

$ANGO stock is down 8% today. Here's what we see in our data.

Quiver Quantitative44d ago

AngioDynamics (ANGO) Stock Price Sinks As Losses Cloud Med Tech Progress

Simply Wall St42d ago

ANGLO AMERICAN PLC (AAL) Equity Price and Quote

London Stock Exchange27d ago

FAQs About ANGO Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for ANGO.

Based on SEC Form 4 disclosures, the Insider Confidence Score for ANGO is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 1 sales by company executives over the last 90 days.

The CEO Conviction Index for ANGO is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.